Sort
78,016 grants matching “breast cancer”
New Leads for Triple Negative Breast Cancer from Diverse Natural Sources
$459,144Susan L Mooberry · University Of Texas Hlth Science Center · U01 · FY2018 · CA
New Leads for Triple Negative Breast Cancer from Diverse Natural Sources
$459,144Susan L Mooberry · University Of Texas Hlth Science Center · U01 · FY2016 · CA
Mechanism of p53-dependent Tumor Suppression
$459,133Xinbin Chen · University Of California At Davis · R01 · FY2021 · CA
Environmental Effect on the Mammary Gland across the Lifespan
$459,131Zena Werb · University Of California, San Francisco · U01 · FY2014 · ES
Active Delivery of Platinum Nanoimmunoconjugates to Improve Breast Cancer Therapy
$459,080Bogdan Olenyuk · Proteogenomics Research Instit/Sys/ Med · R01 · FY2018 · CA
Stress Induction of Glucose Regulated Protein GRP78/BiP
$459,080Amy S Lee · University Of Southern California · R01 · FY2012 · CA
Project 1: Synthesis, Characterization and Biomonitoring of DNA Containing Site-Specific Chemotherapy-Induced Complex Alkylation Products
$459,053Carmelo J Rizzo · Vanderbilt University · P01 · FY2022 · CA
TARGETED DELIVERY OF ANTICANCER DRUGS TO TUMOR VASCULATURE AND TUMOR IN METASTATIC BREAST CANCER
$459,000Emory University · · FY2008 · Department of the Army
TARGETING ENERGY METABOLIC PATHWAYS AS THERAPEUTIC INTERVENTION FOR BREAST CANCER
$459,000Pennsylvania State University · · FY2011 · Department of the Army
Ratiometric Near-infarared Fluorescent Probes for Sensitive Detection of Lysosomal and Mitochodrial pH changes in Live Cells
$459,000Haiying Liu · Michigan Technological University · R15 · FY2019 · GM
Reflexology: An Intervention for Advanced Breast Cancer
$458,980Gwen Karilyn Wyatt · Michigan State University · R01 · FY2006 · CA
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer Risk
$458,977Shuk-Mei Ho · University Of Cincinnati · U01 · FY2010 · ES
MARSHFIELD COMMUNITY CLINICAL ONCOLOGY PROGRAM
$458,959Marshfield Clinic Research Foundation · U10 · FY2001 · CA
Patterns of Patient Care in Appalachia
$458,946Roger T Anderson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership
$458,929Saraswati Sukumar · Johns Hopkins University · R01 · FY2025 · CA
Microenvironmental contribution of the Choroid Plexus and Cerebral Spinal Fluid in breast to brain metastases
$458,919Josh Neman-Ebrahim · University Of Southern California · R01 · FY2023 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$458,897Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2022 · CA
Observer Studies Involving Search: Modeling and Analysis
$458,883Dev P Chakraborty · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · EB
Matrix density promotes pro-tumorigenic hormone actions in breast cancer
$458,881Linda A. Schuler · University Of Wisconsin-Madison · R01 · FY2024 · CA
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
$458,880Celine Dermardirossian · San Diego Biomedical Research Institute · R01 · FY2018 · CA
Geisinger Clinical Oncology Program
$458,852Albert Michael Bernath · Geisinger Medical Center · U10 · FY2007 · CA
CAREER: Engineering a Liver Sinusoid Functional Unit
$458,851Hongseok Noh · Drexel University · · FY2008 · ENG
Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast Cancer
$458,847Nadezhda A German · Texas Tech University Health Scis Center · R15 · FY2018 · CA
A Search for Small Molecule Inhibitors of the Hypoxia Response Pathway
$458,799Kevin H Gardner · Ut Southwestern Medical Center · P01 · FY2008 · CA
Leveraging the metastatic tumor stroma to limit breast cancer progression
$458,795Sheila A Stewart · Washington University · R01 · FY2024 · CA